1. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

   • Xiao-Dong Zhou
   • Giovanni Targher
   • Ming-Hua Zheng

   Consensus 19 May 2023 Pages: 773 - 791

   

2. Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

   • Virendra Singh
   • Arka De
   • Shiv Kumar Sarin

   Guidelines 26 May 2023 Pages: 792 - 826

   

3. Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma

   • Shuichiro Shiina
   • Hitoshi Maruyama
   • Tatsuya Yamashita

   Editorial Open access 15 May 2023 Pages: 827 - 829

4. Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future

   • Chencheng Xie
   • Ashwani K. Singal

   Editorial 26 April 2023 Pages: 830 - 832

5. Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p

   • Senquan Zhang
   • Jie Yu
   • Hualian Hang

   Original Article 13 April 2023 Pages: 833 - 849

   

6. Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

   • Fan Yang
   • Xiaofang Zheng
   • Wenjie Chen

   Original Article 17 April 2023 Pages: 850 - 859

   

7. Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis

   • Eui Gwon Hwang
   • Eun-Ae Jung
   • Young Seok Kim

   Original Article 26 April 2023 Pages: 860 - 869

   

8. Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy

   • Wah-Loong Chan
   • Shi-En Chong
   • Wah-Kheong Chan

   Original Article 26 May 2023 Pages: 870 - 881

   

9. Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trial

   • Alireza Ramandi
   • Jacob George
   • Reza Malekzadeh

   Original Article 25 May 2023 Pages: 882 - 888

   

10. Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma

    • Ying Xu
    • Guangchao Luan
    • Tao Yang

    Original Article 17 March 2023 Pages: 889 - 903

    

11. Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

    • Mathew Vithayathil
    • Antonio D’Alessio
    • Rohini Sharma

    Original Article Open access 01 April 2023 Pages: 904 - 914

    

12. Transcatheter arterial chemoembolization plus apatinib with or without camrelizumab for unresectable hepatocellular carcinoma: a multicenter retrospective cohort study

    • Xuhua Duan
    • Hao Li
    • Xinwei Han

    Original Article Open access 03 April 2023 Pages: 915 - 926

    

13. Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation

    • Wei-Feng Qu
    • Meng-Xin Tian
    • Ying-Hong Shi

    Original Article Open access 08 April 2023 Pages: 927 - 941

    

14. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma

    • Hyungjin Rhee
    • Hyun-Ji Lim
    • Mi-Suk Park

    Original Article 23 January 2023 Pages: 942 - 953

    

15. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed

    • Amar Mukund
    • Sudhir Vasistha
    • Shiv K. Sarin

    Original Article 14 February 2023 Pages: 954 - 966

    

16. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS

    • Yifu Xia
    • Jun Tie
    • Chunqing Zhang

    Original Article Open access 17 February 2023 Pages: 967 - 978

    

17. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding

    • Jun Tie
    • Xiaoyuan Gou
    • Wenlan Wang

    Original Article Open access 25 April 2023 Pages: 979 - 988

    

18. Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure

    • Sanchit Sharma
    • Samagra Agarwal
    • APASL ACLF Research Consortium (AARC) for APASL ACLF working party

    Original Article 15 February 2023 Pages: 989 - 999

    

19. Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure

    • Yao Zhang
    • Xueyun Zhang
    • Jiming Zhang

    Original Article 22 March 2023 Pages: 1000 - 1015

    

20. Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study

    • Yangda Song
    • Guangyao Zhou
    • Yuanping Zhou

    Original Article 23 February 2023 Pages: 1016 - 1027

    

21. Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044

    • Yang Liu
    • Zhouyi Sun
    • Bo Zhang

    Original Article Open access 05 March 2023 Pages: 1028 - 1044

    

22. Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response

    • Benedikt Simbrunner
    • Esther Caparrós
    • Rubén Francés

    Original Article Open access 07 March 2023 Pages: 1045 - 1056